Search Results

Displaying Results 7051-7075 of 8008 "'III'"

Nov 24, 2025, 06:00 ET Harley-Davidson Financial Services, Inc. Announces Results of Tender Offers for Any and All of its Outstanding 6.500% Medium-Term Notes due 2028 and 5.950% Medium-Term Notes due 2029

Morgan at (866) 834-4666 (toll-free) or (212) 834-3554 (collect), (ii) TD Securities at (866) 584-2096 (toll-free) or (212) 827-2842 (collect), and (iii) Wells Fargo Securities at (866) 309-6316 (toll-free) or (704) 410-4759 (collect). D.F. King & Co., Inc. is the tender and information agent for

More news about: Harley-Davidson, Inc.


Nov 22, 2025, 12:30 ET FLY INVESTOR DEADLINE: Firefly Aerospace Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Spacecraft Solutions offerings; (ii) Firefly Aerospace had overstated the operational readiness and commercial viability of its Alpha rocket program; and (iii) the foregoing, once revealed, would likely have a material negative impact on Firefly Aerospace.The Firefly Aerospace investor class action

More news about: Robbins Geller Rudman & Dowd LLP


Nov 22, 2025, 00:46 ET Republic of Colombia Announces the Expiration of the Tender Offer for its Non-U.S. Dollar Bonds and Final Results of Tender Offer

Promotion) Order 2005 (as amended, the "Order"); or (iii) high net worth entities and other persons to whom it may be lawfully communicated falling within Article 49(2)(a) to (d) of the Order (all such persons falling within (i)-(iii) together being referred to as "relevant persons"). Any investment

More news about: Republic of Colombia


Nov 22, 2025, 00:04 ET Automotores Gildemeister SpA Announces Commencement of Exchange Offers by AG Chile Holding II SpA for Its Outstanding 7.50% Junior Secured Notes due 2027 and 10.00% Subordinated Notes due 2035 and Related Consent Solicitations

Notes and (iii) $30in cash  $1,000 in valueconsisting of (i) $980 in principalamount of New 2035 Notes (asdefined herein)and (iii) $20 incash

More news about: Automotores Gildemeister SpA


Nov 21, 2025, 22:17 ET Six Flags Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Substantial Losses of Lead Plaintiff Deadline in Class Action Lawsuit Against Six Flags Entertainment Corporation - FUN

cost-cutting measures, including significant reductions in employee headcount, which materially degraded operational competence and guest experience; (iii) as a result, Legacy Six Flags required a substantial and undisclosed capital infusion to stabilize and revitalize its business, and these acute capital

More news about: Kahn Swick & Foti, LLC


Nov 21, 2025, 17:30 ET SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-NUVSF, NDTAF, THS, and CDTX

shareholders will have the option to receive either (i) C$18.00 in cash per NuVista common share; (ii) 0.344 of a share of Ovintiv common stock; or (iii) a combination of cash and Ovintiv common stock, prorated so that, on a fully prorated basis, NuVista shareholders will receive C$9.00 in cash plus 0.172

More news about: Monteverde & Associates PC


Nov 21, 2025, 16:30 ET SOLAI Limited Announces Unaudited Financial Results for the Three Months Ended September 30, 2025

US$1.3 million in other operating expenses as we recorded cryptocurrency loss due to an online scam in the second quarter of 2025 and (iii) the decrease of US$0.3 million in cost of reveune.Non-GAAP adjusted net loss attributable to SOLAI was US$2.4 million for the three months ended

More news about: SOLAI Limited


Nov 21, 2025, 16:00 ET Ziegler Closes $80,000,000 Financing for Brazos Presbyterian Homes

expenditures at BPH's retirement communities; (ii) refund portions of outstanding indebtedness to reduce interest expense and eliminate bank renewal risk; (iii) establish a debt service reserve fund; and (iv) pay associated costs of issuance for the Series 2025 Bonds.Deidre Kinsey, Chief Executive Officer

More news about: Ziegler


Nov 21, 2025, 15:08 ET Harley-Davidson Financial Services, Inc. Announces Pricing of Tender Offers for Any and All of its Outstanding 6.500% Medium-Term Notes due 2028 and 5.950% Medium-Term Notes due 2029

Morgan at (866) 834-4666 (toll-free) or (212) 834-3554 (collect), (ii) TD Securities at (866) 584-2096 (toll-free) or (212) 827-2842 (collect), and (iii) Wells Fargo Securities at (866) 309-6316 (toll-free) or (704) 410-4759 (collect). D.F. King & Co., Inc. is the tender and information agent for

More news about: Harley-Davidson, Inc.


Nov 21, 2025, 09:00 ET VinFast Reports Unaudited Third Quarter 2025 Financial Results

unavailability, reduction or elimination of government and economic incentives or government policies that are favorable for EV manufacturers and buyers; (iii) Significant changes or developments in U.S. laws or policies, including changes in U.S. trade policies and tariffs and the reaction of other countries;

More news about: VinFast


Nov 21, 2025, 08:45 ET Firefly Aerospace Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - FLY

for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'

More news about: Levi & Korsinsky, LLP


Nov 21, 2025, 08:45 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (iii) accordingly, defendants' purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (iv) defendants

More news about: Levi & Korsinsky, LLP


Nov 21, 2025, 08:37 ET Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration

novel immunotherapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy. Verix's Tovana platform integrates advanced analytics, real-world

More news about: Citius Oncology, Inc.


Nov 21, 2025, 08:31 ET Morphy's Two-Part Auction Series Featuring Tom Sage Sr. Antique Toy and Train Collection Tallies Nearly $4 Million

Second and final installment held Oct. 30 was dominated by rare German Marklin productions, including a circa-1904 hand-painted III-Gauge live steam train that sold for $123K against a $50K-$70K estimateDENVER, Pa., Nov.

More news about: Morphy Auctions


Nov 21, 2025, 08:30 ET BitMine Immersion (BMNR) Reports FY25 GAAP EPS of $13.39; 'Made-in-America Validator Network' Ethereum Staking to Commence in Early 2026; Declares Annual Dividend of $0.01, the first large-cap crypto company to pay a dividend

BitMine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support BitMine's goal of acquiring 5% of ETH

More news about: BitMine Immersion Technologies, Inc.


Nov 21, 2025, 08:30 ET BitMine Immersion (BMNR) Reports FY25 GAAP EPS of $13.39; 'Made-in-America Validator Network' Ethereum Staking to Commence in Early 2026; Declares Annual Dividend of $0.01, the first large-cap crypto company to pay a dividend

BitMine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support BitMine's goal of acquiring 5% of ETHLAS

More news about: BitMine Immersion Technologies, Inc.


Nov 21, 2025, 08:04 ET SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting

Impact of Zero Seizures on Healthcare Resource Utilization Among Cenobamate Patients (Stern et al) Poster Number: 2.363III.   Poster Session 3: Monday, Dec. 8; posters on display from 8 AM – 2 PM (authors present from 12 – 1:45 PM)Title: Long-Term

More news about: SK Life Science, Inc.


Nov 21, 2025, 03:22 ET MOEA Takes Home 7 Awards at R&D100

Industries Research & Development Centre (MIRDC) (which also received a Special Recognition award), and one from the Institute for Information Industry (III). The winning technologies span key fields including AI, biomedical and healthcare, and green technology. Standing alongside world-renowned institutions,

More news about: Industrial Technology Research Institute (ITRI)


Nov 21, 2025, 00:52 ET 新橋生物子公司Visara任命兩位眼科領域傑出領袖為首席醫學官和科學顧問委員會主席,加速推進 VIS-101 的全球開發進程

的研發與獲批,負責濕性年齡相關性黃斑變性、糖尿病性黃斑水腫及糖尿病性視網膜病變等關鍵註冊性 III 期研究的設計、執行、數據解讀、註冊申報及上市推進,同時參與 Lucentis® 的適應症擴展策略制定。在 4DMT,他負責推進公司針對視網膜疾病的早期與後期基因治療項目,並領導研發候選藥物 4D-150(用於新生血管性年齡相關性黃斑變性)的臨床試驗設計及全球監管策略。通過他的戰略領導力,該項目顯著縮短研發週期、降低項目風險,並成功促成美國食品藥品監督管理局與歐洲藥品管理局一致認為 4D-150 的 DME 適應症,可以通過單項 III 期臨床試驗提交註冊。Quezada-Ruiz

More news about: 新橋生物


Nov 20, 2025, 17:31 ET Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Advancements in Genetically-targeted Therapies, along with Innovative Treatments such as GLP-1 Receptor Agonists | DelveInsight

Pemvidutide (Altimmune), and others.AD04 is a genetically targeted therapy under investigation for treating AUD and is currently in a Phase III clinical trial. The therapy targets specific genotypes, which are identified through the company's proprietary companion diagnostic genetic test. According

More news about: DelveInsight Business Research, LLP


Nov 20, 2025, 17:00 ET Post Holdings Reports Results for the Fourth Quarter and Fiscal Year 2025

assets, (ii) it presents a measure of corporate performance exclusive of Post's capital structure and the method by which the assets were acquired and (iii) it is a financial indicator of a company's ability to service its debt, as Post is required to comply with certain covenants and limitations that are

More news about: Post Holdings, Inc.


Nov 20, 2025, 16:50 ET X Financial (NYSE: XYF) Reports Q3 2025 Results: Revenue +23.9% YoY, Sequential Decline Amid Rising Credit Costs and Moderating Borrower Activity

use in this press release the following non-GAAP financial measures: (i) adjusted net income (loss), (ii) adjusted net income (loss) per basic ADS, (iii) adjusted net income (loss) per diluted ADS, (iv) adjusted net income (loss) per basic share, and (v) adjusted net income (loss) per diluted share, each

More news about: X Financial


Nov 20, 2025, 16:15 ET MATTHEWS INTERNATIONAL REPORTS RESULTS FOR FOURTH QUARTER AND FISCAL YEAR ENDED SEPTEMBER 30, 2025

performance using the same tools that management uses to budget, forecast, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating the Company's results. The Company's calculations of its non-GAAP

More news about: Matthews International Corporation


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.